Physician profile
Thomas Das
NPI 1295223014
$4,658.00
in general payments reported to CMS, 2019-2025
10 companies · $3,082 in 2025
The $3,082 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $361 · 2024: $1,214 · 2025: $3,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,804 · Travel and Lodging: $853 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,803.85 |
| Travel and Lodging | $853.15 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,929.59 | 2024-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $1,448.98 | 2024-2025 | Dragonfly Opstar, Diamondback Coronary, Portico |
| Medtronic, INC. | $501.60 | 2023-2025 | Corevalve Evolut R, Harmony, Symplicity G3 |
| Cardiovascular Systems INC. | $276.12 | 2023 | Diamondback Coronary |
| Boston Scientific Corporation | $204.03 | 2024-2025 | Avvigo Guidance System, Rotapro, Accolade Sr |
| Abiomed | $198.74 | 2025 | |
| Teleflex LLC | $33.56 | 2025 | Arrow |
| Philips North America LLC | $32.00 | 2025 | Labosys |
| Livanova USA, INC. | $17.60 | 2023 | Lifesparc |
| Terumo Medical Corporation | $15.78 | 2025 | Azur Cx Detachable, Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.